US IPO Market Roars Back: Medline’s $6.3B Deal & the High-Stakes of Pricing in 2026
U.S. IPOs have rebounded in 2025, led by Medl...
Big debuts like Figma, Circle and Chime have ...
Issuance and proceeds are up year over year, ...
Bankers are already positioning for a potenti...
Big debuts like Figma, Circle and Chime have ...
Issuance and proceeds are up year over year, ...
Bankers are already positioning for a potenti...










